CN103880817B - A kind of chemical synthesis process of the chloro- 5- of 3- (3 '-N-Boc- pyrrole radicals) pyridine - Google Patents
A kind of chemical synthesis process of the chloro- 5- of 3- (3 '-N-Boc- pyrrole radicals) pyridine Download PDFInfo
- Publication number
- CN103880817B CN103880817B CN201410067232.9A CN201410067232A CN103880817B CN 103880817 B CN103880817 B CN 103880817B CN 201410067232 A CN201410067232 A CN 201410067232A CN 103880817 B CN103880817 B CN 103880817B
- Authority
- CN
- China
- Prior art keywords
- chloro
- pyridine
- reaction
- boc
- pyrrolyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title claims abstract description 71
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title claims abstract description 35
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 50
- 238000006243 chemical reaction Methods 0.000 claims abstract description 45
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims abstract description 29
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims abstract description 22
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 12
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 claims abstract description 11
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000012312 sodium hydride Substances 0.000 claims abstract description 6
- 229910000104 sodium hydride Inorganic materials 0.000 claims abstract description 6
- 239000012046 mixed solvent Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000003513 alkali Substances 0.000 claims abstract description 3
- 238000002360 preparation method Methods 0.000 claims abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 238000005984 hydrogenation reaction Methods 0.000 claims description 5
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000007868 Raney catalyst Substances 0.000 claims description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 2
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 239000002585 base Substances 0.000 claims 6
- YQMUORJJDBQCOV-UHFFFAOYSA-N $l^{1}-phosphanylmethane Chemical compound [P]C YQMUORJJDBQCOV-UHFFFAOYSA-N 0.000 claims 1
- AFWWKZCPPRPDQK-UHFFFAOYSA-N 6-chloropyridine-3-carbaldehyde Chemical compound ClC1=CC=C(C=O)C=N1 AFWWKZCPPRPDQK-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims 1
- 150000008065 acid anhydrides Chemical class 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 8
- BCELHNLIYYAOLV-UHFFFAOYSA-N 5-chloropyridine-3-carbaldehyde Chemical compound ClC1=CN=CC(C=O)=C1 BCELHNLIYYAOLV-UHFFFAOYSA-N 0.000 abstract description 6
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 238000010189 synthetic method Methods 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- -1 nitrogen heterocyclic compounds Chemical class 0.000 description 20
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- 239000012141 concentrate Substances 0.000 description 12
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 12
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 description 5
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 4
- 150000003233 pyrroles Chemical class 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- GFNNUPBGJQIMMA-UHFFFAOYSA-N nickel radium Chemical compound [Ni].[Ra] GFNNUPBGJQIMMA-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- GNSAQYJBZJPTOF-UHFFFAOYSA-N COC[P] Chemical compound COC[P] GNSAQYJBZJPTOF-UHFFFAOYSA-N 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- LIIBOJGBDQRXAY-UHFFFAOYSA-N methoxymethylphosphane Chemical compound COCP LIIBOJGBDQRXAY-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
本发明涉及一种3‑氯‑5‑(3’‑N‑Boc‑吡咯基)吡啶的化学合成方法。本发明以3‑氯‑5‑吡啶甲醛为原料,经五步反应简易合成了3‑氯‑5‑(3’‑N‑Boc‑吡咯基)吡啶,为该化合物的合成提供了一种高效合成的方法。主要步骤如下:(A)将3‑氯‑5‑吡啶甲醛、甲氧酰甲基磷叶立德和氢化钠,加入四氢呋喃或甲苯溶剂中,控制反应温度,合成了3‑(5’‑氯吡啶基)丙烯酸甲酯;反应合成3‑(5’‑氯吡啶基)‑4‑硝基丁酸甲酯;制备4‑[3‑(5’‑氯吡啶基)]戊内酰胺;反应得到3‑氯‑5‑(3’‑吡咯基)吡啶;将3‑氯‑5‑(3’‑吡咯基)吡啶和Boc酸酐,加入四氢呋喃和水或丙酮和水的混合溶剂中,加入碱氢氧化钠或氢氧化钾,反应得到3‑氯‑5‑(3’‑N‑Boc‑吡咯基)吡啶。The invention relates to a chemical synthesis method of 3-chloro-5-(3'-N-Boc-pyrrolyl)pyridine. The present invention uses 3-chloro-5-pyridine formaldehyde as a raw material, and simply synthesizes 3-chloro-5-(3'-N-Boc-pyrrolyl)pyridine through five-step reactions, and provides a highly efficient compound for the synthesis of the compound synthetic method. The main steps are as follows: (A) 3-chloro-5-pyridine carboxaldehyde, methoxylmethylphosphorylide and sodium hydride are added in tetrahydrofuran or toluene solvent, and the reaction temperature is controlled to synthesize 3-(5'-chloropyridyl ) methyl acrylate; reaction to synthesize 3-(5'-chloropyridyl)-4-methyl nitrobutyrate; preparation of 4-[3-(5'-chloropyridyl)] valerolactam; reaction to obtain 3- Chloro-5-(3'-pyrrolyl)pyridine; add 3-chloro-5-(3'-pyrrolyl)pyridine and Boc anhydride to a mixed solvent of tetrahydrofuran and water or acetone and water, and add alkali sodium hydroxide Or potassium hydroxide, the reaction gives 3-chloro-5-(3'-N-Boc-pyrrolyl)pyridine.
Description
技术领域technical field
本发明涉及一种3-氯-5-(3’-N-Boc-吡咯基)吡啶的化学合成方法。The invention relates to a chemical synthesis method of 3-chloro-5-(3'-N-Boc-pyrrolyl)pyridine.
背景技术Background technique
吡咯衍生物是一类重要的五元氮杂环化合物,广泛地存在于整个自然界,常常具有重要的生理和药理活性。例如,吡咯衍生物在生物体的生长、发育、能量转换以及彼此间各种信息的传递、死亡、腐烂等过程中都有参与。因此,研究吡咯化合物的合成具有非常重要的意义。Pyrrole derivatives are an important class of five-membered nitrogen heterocyclic compounds, which widely exist in the whole nature and often have important physiological and pharmacological activities. For example, pyrrole derivatives are involved in the growth, development, energy conversion and transmission of various information among organisms, death, decay and other processes. Therefore, it is of great significance to study the synthesis of pyrrole compounds.
3-氯-5-(3’-N-Boc-吡咯基)吡啶作为一种重要的吡咯衍生物,在心血管和抗癌药物中有着大量需求,因此对该化合物的合成研究具有重要现实意义。3-Chloro-5-(3'-N-Boc-pyrrolyl)pyridine, as an important pyrrole derivative, is in great demand in cardiovascular and anticancer drugs, so the synthesis of this compound has important practical significance.
发明内容Contents of the invention
本发明的目的是:提供一种3-氯-5-(3’-N-Boc-吡咯基)吡啶的高效化学合成方法。The purpose of this invention is: provide a kind of efficient chemical synthesis method of 3-chloro-5-(3'-N-Boc-pyrrolyl)pyridine.
本发明的技术方案如下:Technical scheme of the present invention is as follows:
一种3-氯-5-(3’-N-Boc-吡咯基)吡啶的化学合成方法,其特征在于,以3-氯-5-吡啶甲醛为原料,经五步反应合成了3-氯-5-(3’-吡咯基)吡啶,合成路线如下:A kind of chemical synthesis method of 3-chloro-5-(3'-N-Boc-pyrrolyl)pyridine, it is characterized in that, take 3-chloro-5-pyridine formaldehyde as raw material, synthesized 3-chloro -5-(3'-pyrrolyl)pyridine, the synthetic route is as follows:
所述的化学合成方法为:Described chemical synthesis method is:
(A)将3-氯-5-吡啶甲醛、甲氧酰甲基磷叶立德和氢化钠,加入四氢呋喃或甲苯溶剂中,控制反应温度,合成了3-(5’-氯吡啶基)丙烯酸甲酯;(A) Add 3-chloro-5-pyridinecarbaldehyde, methoxymethylphosphorylide and sodium hydride to tetrahydrofuran or toluene solvent, control the reaction temperature, and synthesize 3-(5'-chloropyridyl)methyl acrylate ;
(B)将3-(5’-氯吡啶基)丙烯酸甲酯和1,8-二氮杂[5,4,0]十一碳-7-烯(DBU),加入硝基甲烷中,控制反应温度,反应合成3-(5’-氯吡啶基)-4-硝基丁酸甲酯;(B) Add 3-(5'-chloropyridyl)methyl acrylate and 1,8-diaza[5,4,0]undec-7-ene (DBU) into nitromethane, control Reaction temperature, reaction synthesis 3-(5'-chloropyridyl)-4-nitrobutyric acid methyl ester;
(C)将3-(5’-氯吡啶基)-4-硝基丁酸甲酯溶于甲醇或乙醇溶剂中,加入催化剂雷内镍,通入氢气,反应制备4-[3-(5’-氯吡啶基)]戊内酰胺;(C) Dissolve 3-(5'-chloropyridyl)-4-nitrobutyric acid methyl ester in methanol or ethanol solvent, add catalyst Raney nickel, feed hydrogen, and react to prepare 4-[3-(5 '-chloropyridyl)] valerolactam;
(D)将4-[3-(5’-氯吡啶基)]戊内酰胺和氢化铝锂,加入到甲苯或四氢呋喃溶剂中,反应得到3-氯-5-(3’-吡咯基)吡啶;(D) Add 4-[3-(5'-chloropyridyl)]valerolactam and lithium aluminum hydride to toluene or tetrahydrofuran solvent to react to obtain 3-chloro-5-(3'-pyrrolyl)pyridine ;
(E)将3-氯-5-(3’-吡咯基)吡啶和Boc酸酐,加入四氢呋喃和水或丙酮和水的混合溶剂中,加入碱氢氧化钠或氢氧化钾,反应得到3-氯-5-(3’-N-Boc-吡咯基)吡啶。(E) Add 3-chloro-5-(3'-pyrrolyl)pyridine and Boc anhydride to a mixed solvent of tetrahydrofuran and water or acetone and water, add alkali sodium hydroxide or potassium hydroxide, and react to obtain 3-chloro -5-(3'-N-Boc-pyrrolyl)pyridine.
进一步的,在步骤A中,反应温度为-10-20℃。Further, in step A, the reaction temperature is -10-20°C.
进一步的,在步骤B中,反应温度为10-60℃。Further, in step B, the reaction temperature is 10-60°C.
进一步的,在步骤C中,加氢温度为10-60℃。Further, in step C, the hydrogenation temperature is 10-60°C.
进一步的,在步骤D中,反应控制在回流状态。Further, in step D, the reaction is controlled in a reflux state.
进一步的,在步骤E中,反应温度为10-60℃,混合溶剂的体积比为1:0.5-2。Further, in step E, the reaction temperature is 10-60°C, and the volume ratio of the mixed solvent is 1:0.5-2.
本发明的有益效果在于:本发明的化学合成方法,以3-氯-5-吡啶甲醛为原料,经三步反应合成了7-硝基吲哚-3-甲酸叔丁酯,提高了收率,为该化合物的合成提供了一种高效合成的方法。The beneficial effects of the present invention are: the chemical synthesis method of the present invention uses 3-chloro-5-pyridinecarbaldehyde as a raw material, synthesizes tert-butyl 7-nitroindole-3-carboxylate through three-step reaction, and improves the yield , providing an efficient synthetic method for the synthesis of this compound.
具体实施方式Detailed ways
为了加深对本发明的了解,下面将结合实施例对本发明作进一步详述,下列实施例仅用于解释本发明,并不构成对本发明保护范围的限定。In order to deepen the understanding of the present invention, the present invention will be further described below in conjunction with the examples. The following examples are only used to explain the present invention, and do not constitute a limitation to the protection scope of the present invention.
实施例1Example 1
3-(5’-氯吡啶基)丙烯酸甲酯的合成:Synthesis of methyl 3-(5'-chloropyridyl)acrylate:
在三口瓶中加入氢化钠32.0g(石油醚洗涤)和四氢呋喃100mL,控制温度在10℃,甲氧酰甲基磷叶立德78.0g溶解于150mL四氢呋喃,缓慢滴加到反应瓶中。加毕,将3-氯-5-吡啶甲醛50.0g溶于150mL四氢呋喃中,滴加到反应体系中反应1h。反应液倒入500mL冰水中,蒸出四氢呋喃,用二氯甲烷萃取(200mL×3),合并有机相,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得3-(5’-氯吡啶基)丙烯酸甲酯66.7g(95.6%)。Add 32.0g of sodium hydride (washed with petroleum ether) and 100mL of tetrahydrofuran into a three-neck flask, control the temperature at 10°C, dissolve 78.0g of methoxymethylphosphorus ylide in 150mL of tetrahydrofuran, and slowly drop it into the reaction flask. After the addition, 50.0 g of 3-chloro-5-pyridinecarbaldehyde was dissolved in 150 mL of tetrahydrofuran, and added dropwise to the reaction system to react for 1 h. The reaction solution was poured into 500mL of ice water, distilled off tetrahydrofuran, extracted with dichloromethane (200mL×3), the organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated to obtain 3-(5'-chloropyridyl) Methyl acrylate 66.7g (95.6%).
3-(5’-氯吡啶基)-4-硝基丁酸甲酯的合成:Synthesis of 3-(5'-chloropyridyl)-4-nitrobutyric acid methyl ester:
在三口瓶中加入3-(5’-氯吡啶基)丙烯酸甲酯65.0g和硝基甲烷150mL,滴加1,8-二氮杂[5,4,0]十一碳-7-烯(DBU)10.0g,在30℃下反应。反应结束后,蒸出溶剂,乙醇重结晶得3-(5’-氯吡啶基)-4-硝基丁酸甲酯67.4g(79.2%)。Add 65.0g of 3-(5'-chloropyridyl)methyl acrylate and 150mL of nitromethane into a three-necked flask, and dropwise add 1,8-diaza[5,4,0]undec-7-ene ( DBU) 10.0g, react at 30°C. After the reaction, the solvent was distilled off, and recrystallized from ethanol to obtain 67.4 g (79.2%) of methyl 3-(5'-chloropyridyl)-4-nitrobutyrate.
4-[3-(5’-氯吡啶基)]戊内酰胺的合成:Synthesis of 4-[3-(5'-chloropyridyl)]valerolactam:
在三口瓶中加入甲醇400mL、3-(5’-氯吡啶基)-4-硝基丁酸甲酯65.0g和镭内镍15.0g,在30℃下加氢反应。反应结束后,过滤,滤液中加入甲醇钠1g,搅拌1h。浓缩,加入二氯甲烷200mL,碳酸氢钠洗,水洗,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得4-[3-(5’-氯吡啶基)]戊内酰胺40.7g(82.4%)。Add 400 mL of methanol, 65.0 g of methyl 3-(5'-chloropyridyl)-4-nitrobutyrate, and 15.0 g of radium nickel into a three-necked flask, and perform hydrogenation reaction at 30°C. After the reaction was completed, filter, add 1 g of sodium methoxide to the filtrate, and stir for 1 h. Concentrate, add 200mL of dichloromethane, wash with sodium bicarbonate, wash with water, wash with saturated brine, dry over anhydrous sodium sulfate, and concentrate to obtain 40.7g (82.4% ).
3-氯-5-(3’-吡咯基)吡啶的合成:Synthesis of 3-chloro-5-(3'-pyrrolyl)pyridine:
在三口瓶中加入氢化铝锂20.0g,4-[3-(5’-氯吡啶基)]戊内酰胺40.0g溶解于150mL四氢呋喃,缓慢滴加到反应瓶中。加毕,在回流状态下反应1h。过滤,蒸出四氢呋喃,加入二氯甲烷200mL,饱和碳酸氢钠洗,水洗,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得3-氯-5-(3’-吡咯基)吡啶34.8g(93.7%)。Add 20.0 g of lithium aluminum hydride, 40.0 g of 4-[3-(5'-chloropyridyl)]valerolactam in 150 mL of tetrahydrofuran, and slowly drop them into the reaction flask. After the addition, the reaction was carried out under reflux for 1h. Filter, evaporate tetrahydrofuran, add 200 mL of dichloromethane, wash with saturated sodium bicarbonate, wash with water, wash with saturated brine, dry over anhydrous sodium sulfate, and concentrate to obtain 34.8 g of 3-chloro-5-(3'-pyrrolyl)pyridine ( 93.7%).
3-氯-5-(3’-N-Boc-吡咯基)吡啶的合成:Synthesis of 3-chloro-5-(3'-N-Boc-pyrrolyl)pyridine:
在三口瓶中加入四氢呋喃200mL和水200mL,随后加入3-氯-5-(3’-吡咯基)吡啶32.0g、Boc酸酐40.0g和氢氧化钠7.8g,在20℃下反应2h。蒸出四氢呋喃,加入水200mL,二氯甲烷萃取(100mL×3),饱和碳酸氢钠洗,水洗,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得3-氯-5-(3’-N-Boc-吡咯基)吡啶48.5g(97.9%)。Add 200mL of tetrahydrofuran and 200mL of water into a three-necked flask, then add 32.0g of 3-chloro-5-(3'-pyrrolyl)pyridine, 40.0g of Boc anhydride and 7.8g of sodium hydroxide, and react at 20°C for 2h. Evaporate tetrahydrofuran, add 200mL of water, extract with dichloromethane (100mL×3), wash with saturated sodium bicarbonate, wash with water, wash with saturated brine, dry over anhydrous sodium sulfate, and concentrate to obtain 3-chloro-5-(3'-N -Boc-pyrrolyl)pyridine 48.5 g (97.9%).
实施例2Example 2
3-(5’-氯吡啶基)丙烯酸甲酯的合成:Synthesis of methyl 3-(5'-chloropyridyl)acrylate:
在三口瓶中加入氢化钠32.0g(石油醚洗涤)和甲苯100mL,控制温度在10℃,甲氧酰甲基磷叶立德78.0g溶解于150mL甲苯,缓慢滴加到反应瓶中。加毕,将3-氯-5-吡啶甲醛50.0g溶于150mL甲苯中,滴加到反应体系中反应1h。反应液倒入500mL冰水中,蒸出甲苯,用二氯甲烷萃取(200mL×3),合并有机相,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得3-(5’-氯吡啶基)丙烯酸甲酯65.4g(93.7%)。Add 32.0g of sodium hydride (washed with petroleum ether) and 100mL of toluene into the three-necked flask, control the temperature at 10°C, dissolve 78.0g of methoxyacylmethylphosphorus ylide in 150mL of toluene, and slowly drop it into the reaction flask. After the addition, 50.0 g of 3-chloro-5-pyridinecarbaldehyde was dissolved in 150 mL of toluene, and added dropwise to the reaction system to react for 1 h. The reaction solution was poured into 500mL of ice water, the toluene was distilled off, and extracted with dichloromethane (200mL×3), the organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated to obtain 3-(5'-chloropyridyl) Methyl acrylate 65.4 g (93.7%).
3-(5’-氯吡啶基)-4-硝基丁酸甲酯的合成:Synthesis of 3-(5'-chloropyridyl)-4-nitrobutyric acid methyl ester:
在三口瓶中加入3-(5’-氯吡啶基)丙烯酸甲酯65.0g和硝基甲烷150mL,滴加1,8-二氮杂[5,4,0]十一碳-7-烯(DBU)10.0g,在20℃下反应。反应结束后,蒸出溶剂,乙醇重结晶得3-(5’-氯吡啶基)-4-硝基丁酸甲酯67.7g(79.6%)。Add 65.0g of 3-(5'-chloropyridyl)methyl acrylate and 150mL of nitromethane into a three-necked flask, and dropwise add 1,8-diaza[5,4,0]undec-7-ene ( DBU) 10.0g, react at 20°C. After the reaction, the solvent was distilled off and recrystallized from ethanol to obtain 67.7 g (79.6%) of methyl 3-(5'-chloropyridyl)-4-nitrobutyrate.
4-[3-(5’-氯吡啶基)]戊内酰胺的合成:Synthesis of 4-[3-(5'-chloropyridyl)]valerolactam:
在三口瓶中加入乙醇400mL、3-(5’-氯吡啶基)-4-硝基丁酸甲酯65.0g和镭内镍15.0g,在30℃下加氢反应。反应结束后,过滤,滤液中加入甲醇钠1g,搅拌1h。浓缩,加入二氯甲烷200mL,碳酸氢钠洗,水洗,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得4-[3-(5’-氯吡啶基)]戊内酰胺41.4g(83.8%)。Add 400 mL of ethanol, 65.0 g of methyl 3-(5'-chloropyridyl)-4-nitrobutyrate and 15.0 g of radium nickel into a three-necked flask, and perform hydrogenation reaction at 30°C. After the reaction was completed, filter, add 1 g of sodium methoxide to the filtrate, and stir for 1 h. Concentrate, add 200mL of dichloromethane, wash with sodium bicarbonate, wash with water, wash with saturated brine, dry over anhydrous sodium sulfate, and concentrate to obtain 41.4g (83.8% ).
3-氯-5-(3’-吡咯基)吡啶的合成:Synthesis of 3-chloro-5-(3'-pyrrolyl)pyridine:
在三口瓶中加入氢化铝锂20.0g,4-[3-(5’-氯吡啶基)]戊内酰胺40.0g溶解于150mL甲苯,缓慢滴加到反应瓶中。加毕,在回流状态下反应1h。过滤,蒸出甲苯,加入二氯甲烷200mL,饱和碳酸氢钠洗,水洗,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得3-氯-5-(3’-吡咯基)吡啶32.5g(87.5%)。Add 20.0 g of lithium aluminum hydride, 40.0 g of 4-[3-(5'-chloropyridyl)]valerolactam in 150 mL of toluene, and slowly drop them into the reaction flask. After the addition, the reaction was carried out under reflux for 1h. Filter, distill off toluene, add 200 mL of dichloromethane, wash with saturated sodium bicarbonate, wash with water, wash with saturated brine, dry over anhydrous sodium sulfate, and concentrate to obtain 32.5 g of 3-chloro-5-(3'-pyrrolyl)pyridine ( 87.5%).
3-氯-5-(3’-N-Boc-吡咯基)吡啶的合成:Synthesis of 3-chloro-5-(3'-N-Boc-pyrrolyl)pyridine:
在三口瓶中加入四氢呋喃200mL和水200mL,随后加入3-氯-5-(3’-吡咯基)吡啶32.0g、Boc酸酐40.0g和氢氧化钾10.0g,在20℃下反应2h。蒸出四氢呋喃,加入水200mL,二氯甲烷萃取(100mL×3),饱和碳酸氢钠洗,水洗,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得3-氯-5-(3’-N-Boc-吡咯基)吡啶48.7g(98.3%)。Add 200mL of tetrahydrofuran and 200mL of water into a three-necked flask, then add 32.0g of 3-chloro-5-(3'-pyrrolyl)pyridine, 40.0g of Boc anhydride and 10.0g of potassium hydroxide, and react at 20°C for 2h. Evaporate tetrahydrofuran, add 200mL of water, extract with dichloromethane (100mL×3), wash with saturated sodium bicarbonate, wash with water, wash with saturated brine, dry over anhydrous sodium sulfate, and concentrate to obtain 3-chloro-5-(3'-N -Boc-pyrrolyl)pyridine 48.7 g (98.3%).
实施例3Example 3
3-(5’-氯吡啶基)丙烯酸甲酯的合成:Synthesis of methyl 3-(5'-chloropyridyl)acrylate:
在三口瓶中加入氢化钠32.0g(石油醚洗涤)和四氢呋喃100mL,控制温度在0℃,甲氧酰甲基磷叶立德78.0g溶解于150mL四氢呋喃,缓慢滴加到反应瓶中。加毕,将3-氯-5-吡啶甲醛50.0g溶于150mL四氢呋喃中,滴加到反应体系中反应1h。反应液倒入500mL冰水中,蒸出四氢呋喃,用二氯甲烷萃取(200mL×3),合并有机相,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得3-(5’-氯吡啶基)丙烯酸甲酯66.1g(94.7%)。Add 32.0g of sodium hydride (washed with petroleum ether) and 100mL of tetrahydrofuran into a three-necked flask, control the temperature at 0°C, dissolve 78.0g of methoxylmethylphosphonium ylide in 150mL of tetrahydrofuran, and slowly drop it into the reaction flask. After the addition, 50.0 g of 3-chloro-5-pyridinecarbaldehyde was dissolved in 150 mL of tetrahydrofuran, and added dropwise to the reaction system to react for 1 h. The reaction solution was poured into 500mL of ice water, distilled off tetrahydrofuran, extracted with dichloromethane (200mL×3), the organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated to obtain 3-(5'-chloropyridyl) Methyl acrylate 66.1 g (94.7%).
3-(5’-氯吡啶基)-4-硝基丁酸甲酯的合成:Synthesis of 3-(5'-chloropyridyl)-4-nitrobutyric acid methyl ester:
在三口瓶中加入3-(5’-氯吡啶基)丙烯酸甲酯65.0g和硝基甲烷150mL,滴加1,8-二氮杂[5,4,0]十一碳-7-烯(DBU)10.0g,在10℃下反应。反应结束后,蒸出溶剂,乙醇重结晶得3-(5’-氯吡啶基)-4-硝基丁酸甲酯65.2g(76.6%)。Add 65.0g of 3-(5'-chloropyridyl)methyl acrylate and 150mL of nitromethane into a three-necked flask, and dropwise add 1,8-diaza[5,4,0]undec-7-ene ( DBU) 10.0g, react at 10°C. After the reaction, the solvent was distilled off, and recrystallized from ethanol to obtain 65.2 g (76.6%) of methyl 3-(5'-chloropyridyl)-4-nitrobutyrate.
4-[3-(5’-氯吡啶基)]戊内酰胺的合成:Synthesis of 4-[3-(5'-chloropyridyl)]valerolactam:
在三口瓶中加入甲醇400mL、3-(5’-氯吡啶基)-4-硝基丁酸甲酯65.0g和镭内镍15.0g,在20℃下加氢反应。反应结束后,过滤,滤液中加入甲醇钠1g,搅拌1h。浓缩,加入二氯甲烷200mL,碳酸氢钠洗,水洗,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得4-[3-(5’-氯吡啶基)]戊内酰胺41.2g(83.4%)。Add 400 mL of methanol, 65.0 g of methyl 3-(5'-chloropyridyl)-4-nitrobutyrate and 15.0 g of radium nickel into a three-neck flask, and perform hydrogenation reaction at 20°C. After the reaction was completed, filter, add 1 g of sodium methoxide to the filtrate, and stir for 1 h. Concentrate, add 200mL of dichloromethane, wash with sodium bicarbonate, wash with water, wash with saturated brine, dry over anhydrous sodium sulfate, and concentrate to obtain 41.2g (83.4% ).
3-氯-5-(3’-吡咯基)吡啶的合成:Synthesis of 3-chloro-5-(3'-pyrrolyl)pyridine:
在三口瓶中加入氢化铝锂20.0g,4-[3-(5’-氯吡啶基)]戊内酰胺40.0g溶解于200mL四氢呋喃,缓慢滴加到反应瓶中。加毕,在回流状态下反应1h。过滤,蒸出四氢呋喃,加入二氯甲烷200mL,饱和碳酸氢钠洗,水洗,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得3-氯-5-(3’-吡咯基)吡啶33.5g(90.2%)。Add 20.0 g of lithium aluminum hydride, 40.0 g of 4-[3-(5'-chloropyridyl)]valerolactam in 200 mL of tetrahydrofuran, and slowly drop them into the reaction flask. After the addition, the reaction was carried out under reflux for 1h. Filter, evaporate tetrahydrofuran, add 200 mL of dichloromethane, wash with saturated sodium bicarbonate, wash with water, wash with saturated brine, dry over anhydrous sodium sulfate, and concentrate to obtain 33.5 g of 3-chloro-5-(3'-pyrrolyl)pyridine ( 90.2%).
3-氯-5-(3’-N-Boc-吡咯基)吡啶的合成:Synthesis of 3-chloro-5-(3'-N-Boc-pyrrolyl)pyridine:
在三口瓶中加入四氢呋喃150mL和水250mL,随后加入3-氯-5-(3’-吡咯基)吡啶32.0g、Boc酸酐40.0g和氢氧化钠7.8g,在20℃下反应2h。蒸出四氢呋喃,加入水200mL,二氯甲烷萃取(100mL×3),饱和碳酸氢钠洗,水洗,饱和食盐水洗涤,无水硫酸钠干燥,浓缩得3-氯-5-(3’-N-Boc-吡咯基)吡啶46.2g(93.3%)。Add 150mL of tetrahydrofuran and 250mL of water into a three-necked flask, then add 32.0g of 3-chloro-5-(3'-pyrrolyl)pyridine, 40.0g of Boc anhydride and 7.8g of sodium hydroxide, and react at 20°C for 2h. Evaporate tetrahydrofuran, add 200mL of water, extract with dichloromethane (100mL×3), wash with saturated sodium bicarbonate, wash with water, wash with saturated brine, dry over anhydrous sodium sulfate, and concentrate to obtain 3-chloro-5-(3'-N -Boc-pyrrolyl)pyridine 46.2 g (93.3%).
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410067232.9A CN103880817B (en) | 2014-02-26 | 2014-02-26 | A kind of chemical synthesis process of the chloro- 5- of 3- (3 '-N-Boc- pyrrole radicals) pyridine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410067232.9A CN103880817B (en) | 2014-02-26 | 2014-02-26 | A kind of chemical synthesis process of the chloro- 5- of 3- (3 '-N-Boc- pyrrole radicals) pyridine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103880817A CN103880817A (en) | 2014-06-25 |
CN103880817B true CN103880817B (en) | 2018-12-18 |
Family
ID=50949984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410067232.9A Active CN103880817B (en) | 2014-02-26 | 2014-02-26 | A kind of chemical synthesis process of the chloro- 5- of 3- (3 '-N-Boc- pyrrole radicals) pyridine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103880817B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1642899A (en) * | 2002-01-25 | 2005-07-20 | 格吕伦塔尔有限公司 | Methods for producing substituted acrylic acid esters and use of the latter for producing substituted dollar G(G)-amino acids |
WO2010051245A1 (en) * | 2008-11-03 | 2010-05-06 | Merck Sharp & Dohme Corp. | Benzimidazole and aza-benzimidazole carboxamides |
CN101759565A (en) * | 2010-01-26 | 2010-06-30 | 华东师范大学 | Method for synthesizing 6-halogeno-2-naphthoate |
WO2010077624A1 (en) * | 2008-12-09 | 2010-07-08 | Merck Sharp & Dohme Corp. | Biaryl carboxamides |
CN103232356A (en) * | 2013-05-15 | 2013-08-07 | 天津聚德科技有限公司 | Technology for preparing 3-phenyl-4-aminobutyric acid hydrochloride |
-
2014
- 2014-02-26 CN CN201410067232.9A patent/CN103880817B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1642899A (en) * | 2002-01-25 | 2005-07-20 | 格吕伦塔尔有限公司 | Methods for producing substituted acrylic acid esters and use of the latter for producing substituted dollar G(G)-amino acids |
WO2010051245A1 (en) * | 2008-11-03 | 2010-05-06 | Merck Sharp & Dohme Corp. | Benzimidazole and aza-benzimidazole carboxamides |
WO2010077624A1 (en) * | 2008-12-09 | 2010-07-08 | Merck Sharp & Dohme Corp. | Biaryl carboxamides |
CN101759565A (en) * | 2010-01-26 | 2010-06-30 | 华东师范大学 | Method for synthesizing 6-halogeno-2-naphthoate |
CN103232356A (en) * | 2013-05-15 | 2013-08-07 | 天津聚德科技有限公司 | Technology for preparing 3-phenyl-4-aminobutyric acid hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
CN103880817A (en) | 2014-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101934096B1 (en) | Method for preparing idelalisib | |
JP2012521377A5 (en) | ||
JP2015533852A5 (en) | ||
Xu et al. | Efficient synthesis of furoquinolinones using Hendrickson reagent-initiated cascade annulation | |
CN103087139B (en) | A kind of canrenone derivatives class steroidal compounds, its preparation method and the purposes in preparing eplerenone thereof | |
CN103755644B (en) | Compound, synthesis thereof and method for synthesizing double UPy substituted compound by using compound | |
CN103304478B (en) | Alkaloidal intermediate of one class synthesis renieramycins type and preparation method thereof | |
CN103880817B (en) | A kind of chemical synthesis process of the chloro- 5- of 3- (3 '-N-Boc- pyrrole radicals) pyridine | |
CN104610267B (en) | Method for efficiently synthesizing 6-alkyl pyrazolo [1,5-c ] quinazoline framework compound under non-catalytic condition | |
CN106588921A (en) | Synthetic method for 7-azaindole-3-methyl formate | |
CN103709101B (en) | Synthetic intermediate of one class renieramycin G and preparation method thereof | |
Held et al. | One-pot route to β-adrenergic blockers via enantioselective organocatalysed epoxidation of terminal alkenes as a key step | |
CN107513056B (en) | A kind of synthetic method of quinoline compound containing tetrahydrofuran group | |
Shcherbinin et al. | CuBr2 catalyzed synthesis of 3-furylphthalides | |
CN104072495A (en) | Method for preparing natural product alkaloid Aaptamine | |
CN104710417A (en) | Azaindole derivatives and synthesis method thereof | |
CN107721917B (en) | A kind of green synthesis method of polysubstituted nicotinic acid ester compounds | |
CN102199154A (en) | Novel synthesis method for pyrrole derivatives | |
JP2019509293A (en) | 4-Pentafluorothiophenol compounds and preparation method, and preparation method of pentafluorosulfur-substituted benzopyran compounds | |
CN109970643A (en) | A kind of green synthesis method of tetrahydroacridine compound under the promotion of iodine anion | |
CN102276576B (en) | Benzamide compound and preparation method thereof | |
CN112624966B (en) | Synthetic method of 2-aminomethyl-4-methyl-5-pyridine carboxylic acid | |
CN102476983A (en) | Synthetic method of 6-methoxy-2-naphthaldehyde | |
CN101824010A (en) | Method for synthesizing 4-aryl-4,5-dihydrofuran | |
CN104592178B (en) | A kind of preparation method of dehydroabietic acid lactone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201016 Address after: 226019 No.205, building 6, Nantong University, No.9, Siyuan Road, Nantong City, Jiangsu Province Patentee after: Center for technology transfer, Nantong University Address before: Nantong City, Jiangsu province 226019 Road No. 9 Patentee before: NANTONG University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201217 Address after: 8319 Yanshan Road, Bengbu City, Anhui Province Patentee after: Bengbu Lichao Information Technology Co.,Ltd. Address before: 226019 No.205, building 6, Nantong University, No.9, Siyuan Road, Nantong City, Jiangsu Province Patentee before: Center for technology transfer, Nantong University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210430 Address after: 210043 rooms 1501-1504 and 1506, building D, No. 606, ningliu Road, Changlu street, Jiangbei new district, Nanjing City, Jiangsu Province Patentee after: Nanjing dekerui Pharmaceutical Chemical Co.,Ltd. Address before: 8319 Yanshan Road, Bengbu City, Anhui Province Patentee before: Bengbu Lichao Information Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |